Skip to main content

Georgetown University confirms omicron case

(Editor’s note: This story has been updated to indicate the transmission did not occur on Georgetown’s campus.)

Georgetown University said Monday that one of D.C.’s four COVID-19 omicron variant cases involves a member of the Georgetown community.

“The individual is fully vaccinated, asymptomatic and had recently returned from domestic travel,” said, Dr. Ranit Mishori, vice president and chief public health officer for Georgetown in a letter to the community.



“Testing was conducted by Georgetown University’s COVID-19 testing lab, and the genomic sequencing confirming the Omicron variant was conducted at the National Institutes of Health (NIH) Vaccine Research Center. We are coordinating closely with DC Health on this case and will do the same for any future cases.”

Mishori said that the transmission of the variant didn’t occur on campus. The university’s weekly positivity rate for COVID-19 still remains below 1%.

“Any Georgetown community members who test positive for COVID-19, including the Omicron variant, will continue to be notified by our contact tracing team and given instructions for isolation,” Mishori said.

 

Md. vaccine policy ‘will be led by science’: New law decouples guidance from federal agencies

As of July 1, Maryland will determine which vaccines should be administered, severing its reliance on federal agencies, including the U.S. Centers for Disease Control and Prevention. The Vax Act, signed Tuesday by Gov. Wes Moore, authorizes Maryland's health secretary to set recommendations for immunizations, screenings and preventive services. It also requires insurance companies to cover vaccines endorsed by the state.
Read Next Story